Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Farmakoekonomika is Scopus-indexed (Q3, CiteScore 1.2), DOAJ. Published by IRBIS LLC.
Checked against the index lists dated .
ISSN 2070-4909Verify ISSN ↗2070-4933Verify ISSN ↗
Publisher: IRBIS LLC
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Public Health, Environmental and Occupational Health | 531 / 725 | 26th | Q3 |
| Health Policy | 245 / 330 | 25th | Q3 |
| Pharmacology | 265 / 328 | 19th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q3, CiteScore 1.2.
Farmakoekonomika is Q3 in Public Health, Environmental and Occupational Health (rank 531 of 725), Q3 in Health Policy (rank 245 of 330) and Q4 in Pharmacology (rank 265 of 328), by CiteScore 2025.
Farmakoekonomika is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.2, quartile Q3, 26th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.159, quartile Q4, with an H-index of 11.
The publisher lists an article processing charge of about US$142 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Farmakoekonomika is published by IRBIS LLC. Its print ISSN is 2070-4909 and its online ISSN is 2070-4933.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Farmakoekonomika has an h-index of 15 and a 2-year mean of 1.13 citations per paper (OpenAlex). Its Scopus CiteScore is 1.2, quartile Q3. On 2-year citations it ranks #423 of 710 Scopus journals in Public Health, Environmental and Occupational Health.
Farmakoekonomika published 49 papers in 2025; its busiest recent year was 2023 with 65. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 83 research articles (2025–2026), authors are most often from Russia (86.7%), Uzbekistan (8.4%) and Kyrgyzstan (1.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.